Assuntos
Antineoplásicos/uso terapêutico , Invasividade Neoplásica , Recidiva Local de Neoplasia/diagnóstico , Disco Óptico/patologia , Neoplasias da Retina/tratamento farmacológico , Retinoblastoma/tratamento farmacológico , Seguimentos , Humanos , Lactente , Masculino , Neoplasias da Retina/patologia , Retinoblastoma/patologiaRESUMO
Trilateral retinoblastoma (TRB) is a rare condition characterized by an intracranial neuroblastic tumor associated with bilateral or unilateral retinoblastoma (RB). The outcome is almost always fatal. An 18-month-old patient with familial bilateral RB was referred for a pineal lesion detected on a screening by magnetic resonance imaging. The child, considered inoperable by 2 different neurosurgical teams, was treated with conventional chemotherapy (methotrexate, vincristine, vepeside, cyclophosphamide, and carboplatin) plus tandem transplantation (vepeside/carboplatin and thiotepa/mephalan) followed by local radiotherapy. At 80 months from the diagnosis of TRB, the patient is alive and in complete remission, with no neuropsychologic consequences. An early and aggressive treatment may improve the prognosis of TRB.